Latest Co-stimulation Stories
Newborns are more susceptible to infections, presumably because of their immature and inexperienced immune systems.
In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs.
ROCKVILLE, Md., Aug. 4 /PRNewswire/ -- Amplimmune, Inc. today announced that it has entered into a broad strategic alliance with GlaxoSmithKline (GSK) to further develop PD-1 targeting therapies that may be effective in the treatment of cancer and other diseases.
By Rajavelu, Priya Das, Sulochana D Background & objectives: Activation of T cells is mediated through two critical signals provided by activated macrophages. The first signal is triggered when T cell receptor (TCR) binds to the major histocompatibility antigen (MHC/Ag) complex.
In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.
A group of scientists at The Scripps Research Institute has solved a mystery that has dogged immunologists for many years: how T-cell receptors interact with their coreceptor proteins at the beginning of an immune response.
- Growing in low tufty patches.